CORONA Remedies Limited (NSE:CORONA)
2,236.70
-19.50 (-0.86%)
At close: Nov 19, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 136.8 billion as of November 18, 2026. It is the 7,779th most valuable company in the world and the 492nd biggest in India.
Market Cap
136.80B
Enterprise Value
136.96B
Revenue
15.59B
Global Rank
Country Rank
#492 India
PE Ratio
66.08
ChartMarket Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 136.80B, an increase of 55.50%. That is a compound annual growth rate of 60.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 136.80B | 61.51% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.49T |
| Divi's Laboratories | 2.93T |
| Apollo Hospitals Enterprise | 1.27T |
| Lenskart Solutions | 1.27T |
| NATCO Pharma | 160.52B |
| Vijaya Diagnostic Centre | 158.62B |
| Indegene | 158.03B |
| Sudeep Pharma | 135.98B |